Login / Signup

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy.

Taku FujimuraYumi KambayashiYota SatoKayo TanitaHisayuki TonoChunbing LyuToshiya TakahashiAkira HashimotoSetsuya Aiba
Published in: The Journal of dermatology (2019)
Keyphrases
  • locally advanced
  • combination therapy
  • advanced non small cell lung cancer
  • chronic rhinosinusitis
  • liver metastases
  • open label
  • rectal cancer
  • squamous cell carcinoma
  • clinical trial
  • randomized controlled trial